Evidence map›Paper›PMID 37432746›Full record

ArticleJCI insight2023

Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction.

Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu and 3 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. lncRNAInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 2 countries.

Yang YuDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Haiqiong YangDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Qiuting LiDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Nianhui DingDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Jiali GaoDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Gan QiaoDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Jianguo FengDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Xin ZhangDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Jianming WuSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Yajun YuDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Xiangyu ZhouDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Xiaobin WangDepartment of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China .
Chunxiang ZhangDepartment of Cardiology, The Affiliated Hospital of Southwest Medical University.
Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid RNA regulator of Bim-induced death (Morrbid) is a newly identified leukocyte-specific long noncoding RNA (lncRNA). However, the expression and biological functions of Morrbid in cardiomyocytes and heart disease are currently unclear. This study was meant to determine the role of cardiac Morrbid in acute myocardial infarction (AMI) and to identify the potential cellular and molecular mechanisms involved. We found that both human and mouse cardiomyocytes could express a significant amount of Morrbid and that its expression was increased in cardiomyocytes with hypoxia or oxidative stress as well as in mouse hearts with AMI. Overexpression of Morrbid reduced the myocardial infarct size and cardiac dysfunction, whereas the infarct size and cardiac dysfunction deteriorated in cardiomyocyte-specific Morrbid-KO (Morrbidfl/fl/Myh6-Cre) mice. We identified that Morrbid had a protective effect against hypoxia- or H2O2-induced apoptosis; this was also confirmed in vivo in mouse hearts after AMI. We further discovered that serpine1 was a direct target gene of Morrbid that was involved in the Morrbid-mediated protective effect on cardiomyocytes. In summary, we have found, for the first time to our knowledge, that the cardiac Morrbid is a stress-enhanced lncRNA that protects hearts from AMI via antiapoptosis through its target gene serpine1. Morrbid may be a novel promising therapeutic target for ischemic heart diseases such as AMI.

Indexed as

Myocardial InfarctionMyocardial IschemiaRNA, Long NoncodingAnimalsHumansHydrogen PeroxideHypoxiaMiceHydrogen PeroxideRNA, Long NoncodingApoptosisCardiologyCardiovascular diseaseCell BiologyNoncoding RNAs

Identifiers

PMID37432746
PMCPMC10543728
OpenAlexW4383871988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.